Supplement: TX HB3286 | 2023-2024 | 88th Legislature | Fiscal Note (House Committee Report)
For additional supplements on Texas HB3286 please see the Bill Drafting List
Bill Title: Relating to prescription drug benefits under Medicaid and the child health plan program.
Status: 2023-06-12 - Effective on 9/1/23 [HB3286 Detail]
Download: Texas-2023-HB3286-Fiscal_Note_House_Committee_Report_.html
Bill Title: Relating to prescription drug benefits under Medicaid and the child health plan program.
Status: 2023-06-12 - Effective on 9/1/23 [HB3286 Detail]
Download: Texas-2023-HB3286-Fiscal_Note_House_Committee_Report_.html
| TO: |
Honorable Sam Harless, Chair, House Committee on Health Care Reform, Select |
| FROM: |
Jerry McGinty, Director, Legislative Budget Board
|
| IN RE: |
HB3286 by Klick (relating to certain prescription drug benefits under the Medicaid managed care program.), Committee Report 1st House, Substituted |
The fiscal implications of the bill cannot be determined due to the uncertainty regarding the number of clients who would shift to non-preferred drugs as a result of exceptions to the preferred drug list.
The bill would establish exceptions to the preferred drug list adhered to by Medicaid managed care organizations. According to the Health and Human Services Commission, the bill could result in a reduction of federal and supplemental rebates due to a shift towards higher net cost non-preferred drugs. However, due to a lack of information regarding the effects on utilization, the fiscal impact cannot be determined at this time.
Local Government Impact
No fiscal implication to units of local government is anticipated.
| Source Agencies: | 529 Health and Human Services Commission |
| LBB Staff: | JMc, NPe, ER, CST |
